News for Agent

Daily business news: funding, M&A, launches

IPOs & Listings

Medline Launches 60 Million Share Secondary Offering With $200 Million Buyback

By ·

Key takeaways

  • Medline's selling stockholders launched an underwritten offering of 60 million Class A shares, with a 30-day option for 9 million more.
  • Medline will not sell shares or receive proceeds, and agreed to repurchase $200 million of Class A stock and Common Units from the sellers.
  • Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are global coordinators and joint bookrunning managers for the offering.

Medline Inc. Launched an underwritten public offering of 60 million Class A common shares on November 16, 2026, with selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, GIC and a subsidiary of the Abu Dhabi Investment Authority. The GlobeNewswire announcement said the sellers intend to grant underwriters a 30-day option for up to 9 million additional shares.

Medline's Offering Terms and Repurchase

Medline is not selling any shares in the offering and will not receive any proceeds. The selling stockholders also agreed to a private, non-underwritten repurchase by Medline and Medline Holdings of $200 million of Class A common stock and limited partnership interests, at a price per equity interest equal to the price paid by the underwriters. The repurchase is expected to close concurrently with the offering and is conditioned on the offering closing, while the offering is not conditioned on the repurchase. The Audit Committee of Medline's board approved the repurchase, which counts toward the company's previously announced share repurchase program.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities and J.P. Morgan are global coordinators and joint bookrunning managers, with Blackstone Capital Markets and Carlyle as co-managers. Morgan Stanley's role as a bookrunner follows its November 16 assessment that the recent tech sell-off was an overreaction, as reported by Trending Topics.

Medline's Buyback and Layoffs Before the Offering

Medline announced a share repurchase program of up to $1,000 million of Class A common stock and/or units of Medline Holding LP on November 4, 2026, MarketScreener reported. That same day, the Chicago Tribune reported that the Northfield-based medical supply company is laying off 304 workers, mostly corporate employees, as part of an operational simplification effort. On November 14, TASS reported that Medline recalled its products and stopped production in October after seven deaths and 35 serious injuries were linked to the goods, with those reports received as of November 8, 2026.

How Medline's Offering Compares With Other Listings

Bloomberg reported on November 3 that Oracle Corp. Is pricing a $10 billion share sale at $116 per share, an 11% discount from Friday's close of $130.67. The Oman Observer reported on November 5 that the FSA approved the allocation results of Asyad Shipping's secondary offering, which reached 335,312,913 shares, or 6.44% of issued capital, at 195 baisas per share. SeeNews reported on November 3 that North Macedonia's TE-TO will auction treasury shares representing a 0.8% stake for 41.1 million denars ($747,612) on the Macedonian Stock Exchange on November 17.

Medline's Registration Statement Status

Medline filed a registration statement with the SEC relating to the securities, and it has not yet become effective. The company said the offering will be made only by means of a prospectus.

Companies in this story

Sources

Machine-readable: Markdown · JSON